|
EP1502601B2
(en)
|
1997-07-15 |
2010-07-21 |
The Regents of the University of Colorado |
Use of neurotoxin therapy for treatment of urinary retention
|
|
US9066943B2
(en)
|
1997-07-15 |
2015-06-30 |
The Regents Of The University Of Colorado |
Use of botulinum toxin therapy for treatment of urological neurological conditions
|
|
US7470431B2
(en)
|
1997-07-15 |
2008-12-30 |
The Regents Of The University Of Colorado |
Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer
|
|
US7455845B2
(en)
|
1997-07-15 |
2008-11-25 |
The Regents Of The University Of Colorado |
Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure
|
|
US7449192B2
(en)
|
1997-07-15 |
2008-11-11 |
The Regents Of The University Of Colorado |
Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction
|
|
NZ514418A
(en)
*
|
1999-04-01 |
2003-11-28 |
Heeling Sports Ltd |
Heeling apparatus and method, with roller in heel portion of shoe
|
|
DE19925739A1
(de)
*
|
1999-06-07 |
2000-12-21 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum mit einem Botulinum-Neurotoxin
|
|
US7838007B2
(en)
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating mammary gland disorders
|
|
US7838008B2
(en)
*
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating diverse cancers
|
|
US6773711B2
(en)
|
2000-02-15 |
2004-08-10 |
Allergan, Inc. |
Botulinum toxin therapy for Hashimoto's thyroiditis
|
|
US6524580B1
(en)
|
2000-02-15 |
2003-02-25 |
Allergan Sales, Inc. |
Method for treating thyroid disorders
|
|
US6821520B2
(en)
|
2000-02-15 |
2004-11-23 |
Allergan, Inc. |
Clostridial toxin therapy for Hashimoto's thyroiditis
|
|
US6358513B1
(en)
|
2000-02-15 |
2002-03-19 |
Allergan Sales, Inc. |
Method for treating Hashimoto's thyroiditis
|
|
US20050214327A1
(en)
*
|
2000-06-02 |
2005-09-29 |
Allergan, Inc. |
Neurotoxin-containing suppositories and related methods
|
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
US20040170665A1
(en)
*
|
2000-06-02 |
2004-09-02 |
Allergan, Inc. |
Intravitreal botulinum toxin implant
|
|
US6306403B1
(en)
*
|
2000-06-14 |
2001-10-23 |
Allergan Sales, Inc. |
Method for treating parkinson's disease with a botulinum toxin
|
|
US6903187B1
(en)
*
|
2000-07-21 |
2005-06-07 |
Allergan, Inc. |
Leucine-based motif and clostridial neurotoxins
|
|
US7491799B2
(en)
*
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
|
US20040219619A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Ester Fernandez-Salas |
Methods of identifying compounds that alter toxin persistence and/or protease activity
|
|
US7691983B2
(en)
*
|
2000-07-21 |
2010-04-06 |
Allergan, Inc. |
Chimera botulinum toxin type E
|
|
GB0029125D0
(en)
*
|
2000-11-29 |
2001-01-10 |
Specialistkliniken I Varberg H |
Novel treatment
|
|
JP4707254B2
(ja)
*
|
2001-04-24 |
2011-06-22 |
クミアイ化学工業株式会社 |
粒状組成物及びその製造方法
|
|
ATE497765T1
(de)
*
|
2001-07-10 |
2011-02-15 |
Astellas Pharma Inc |
Pharmazeutische zusammensetzung enthaltend quinuclidin-3'-yl 1-phenyl-1,2,3,4,- tetrahydroisoquinolin-2-carboxylat zur behandlung der interstitiellen cystitis und/oder der abakteriellen prostatitis
|
|
US6984375B2
(en)
*
|
2001-08-03 |
2006-01-10 |
Allergan, Inc. |
Nuclei density and nuclei area methods for determining effects of a botulinum toxin on muscles
|
|
AU2002323151A1
(en)
*
|
2001-08-13 |
2003-03-03 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
|
US8110217B2
(en)
*
|
2001-08-13 |
2012-02-07 |
University Of Pittsburgh |
Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
|
|
US20100104631A1
(en)
*
|
2001-08-13 |
2010-04-29 |
Lipella Pharmaceuticals Inc. |
Method of treatment for bladder dysfunction
|
|
US7255866B2
(en)
|
2001-09-17 |
2007-08-14 |
Allergan, Inc. |
Botulinum toxin therapy for fibromyalgia
|
|
US6623742B2
(en)
|
2001-09-17 |
2003-09-23 |
Allergan, Inc. |
Methods for treating fibromyalgia
|
|
HUP0402268A2
(hu)
*
|
2001-11-15 |
2005-02-28 |
Micro Algae Corp. |
3,4-propinoperhidropurinokat tartalmazó gyógyászati kompozíciók és alkalmazásuk ingerületátvitel gátlására
|
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
|
US6688311B2
(en)
|
2002-03-14 |
2004-02-10 |
Allergan, Inc. |
Method for determining effect of a clostridial toxin upon a muscle
|
|
US7140371B2
(en)
|
2002-03-14 |
2006-11-28 |
Allergan, Inc. |
Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins
|
|
US7691394B2
(en)
|
2002-05-28 |
2010-04-06 |
Botulinum Toxin Research Associates, Inc. |
High-potency botulinum toxin formulations
|
|
US6776991B2
(en)
*
|
2002-06-26 |
2004-08-17 |
Allergan, Inc. |
Methods for treating priapism
|
|
WO2004010934A2
(en)
*
|
2002-07-29 |
2004-02-05 |
Rajiv Doshi |
Methods for the use of neurotoxin in the treatment of urologic disorders
|
|
US20040086532A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
|
US7238357B2
(en)
*
|
2002-11-05 |
2007-07-03 |
Allergan, Inc. |
Methods for treating ulcers and gastroesophageal reflux disease
|
|
GB2398636A
(en)
*
|
2003-02-21 |
2004-08-25 |
Ipsen Ltd |
Method for determining the quantity of pre-synaptic neuromuscular blocking substance contained in a sample
|
|
US8071550B2
(en)
*
|
2003-03-03 |
2011-12-06 |
Allergan, Inc. |
Methods for treating uterine disorders
|
|
US7335367B2
(en)
*
|
2003-03-06 |
2008-02-26 |
Botulinum Toxin Research Associates, Inc. |
Treatment of chronic chalazion and hordeolum with botulinum toxin
|
|
KR20050109969A
(ko)
*
|
2003-03-06 |
2005-11-22 |
보툴리늄 톡신 리서치 어쏘시에이츠, 인크. |
보툴리눔 톡신으로 부비동염 관련 만성 안면통 및 두통을치료하는 방법
|
|
US7422753B2
(en)
*
|
2003-04-25 |
2008-09-09 |
Allergan, Inc. |
Methods for treating trichotillomania
|
|
US7393538B2
(en)
*
|
2003-04-25 |
2008-07-01 |
Ackerman Alan H |
Clostridial toxin treatment for dermatillomania
|
|
US7396535B2
(en)
*
|
2003-04-25 |
2008-07-08 |
Ackerman Alan H |
Therapy for obsessive compulsive head banging
|
|
US7390496B2
(en)
*
|
2003-04-25 |
2008-06-24 |
Allergan, Inc. |
Therapeutic treatments for repetitive hand washing
|
|
US7393537B2
(en)
|
2003-04-25 |
2008-07-01 |
Allergan, Inc. |
Botulinum toxin for treatment of obsessive compulsive finger biting disorder
|
|
US6838434B2
(en)
*
|
2003-05-02 |
2005-01-04 |
Allergan, Inc. |
Methods for treating sinus headache
|
|
US7220422B2
(en)
*
|
2003-05-20 |
2007-05-22 |
Allergan, Inc. |
Methods and compositions for treating eye disorders
|
|
US20040253274A1
(en)
*
|
2003-06-11 |
2004-12-16 |
Allergan, Inc. |
Use of a clostridial toxin to reduce appetite
|
|
US20050013850A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Caers Jan K. |
Device to assist hyperhydrosis therapy
|
|
US8609113B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US8609112B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US8734810B2
(en)
|
2003-10-29 |
2014-05-27 |
Allergan, Inc. |
Botulinum toxin treatments of neurological and neuropsychiatric disorders
|
|
US8617572B2
(en)
|
2003-10-29 |
2013-12-31 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US20050096549A1
(en)
*
|
2003-10-31 |
2005-05-05 |
Medtronic, Inc. |
Techniques for transperineal delivery of a denervating agent to the prostate gland
|
|
US7437194B2
(en)
*
|
2003-10-31 |
2008-10-14 |
Medtronic, Inc. |
Stimulating the prostate gland
|
|
US20050096629A1
(en)
*
|
2003-10-31 |
2005-05-05 |
Medtronic, Inc. |
Techniques for transurethral delivery of a denervating agent to the prostate gland
|
|
US20050096550A1
(en)
*
|
2003-10-31 |
2005-05-05 |
Medtronic, Inc. |
Techniques for transrectal delivery of a denervating agent to the prostate gland
|
|
US7172764B2
(en)
*
|
2003-11-17 |
2007-02-06 |
Allergan, Inc. |
Rescue agents for treating botulinum toxin intoxications
|
|
GB0328060D0
(en)
*
|
2003-12-04 |
2004-01-07 |
Sod Conseils Rech Applic |
Botulinum toxin treatment
|
|
US20050129677A1
(en)
*
|
2003-12-10 |
2005-06-16 |
Shengwen Li |
Lipid rafts and clostridial toxins
|
|
US20050148935A1
(en)
*
|
2003-12-29 |
2005-07-07 |
Rozalina Dimitrova |
Botulinum toxin injection guide
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
EP1824488B1
(en)
*
|
2004-05-07 |
2017-08-09 |
Algenis SpA |
Phycotoxins and uses thereof
|
|
CA2607206C
(en)
*
|
2004-05-07 |
2016-06-14 |
Phytotox Limited |
Transdermal administration of phycotoxins
|
|
WO2006130161A2
(en)
*
|
2004-07-21 |
2006-12-07 |
The Cornell Research Foundation, Inc. |
Therapeutic compounds derived from spider venom and their method of use
|
|
US20060024794A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Shengwen Li |
Novel methods for production of di-chain botulinum toxin
|
|
DK1776137T3
(en)
*
|
2004-08-04 |
2015-01-05 |
Ipsen Biopharm Ltd |
A pharmaceutical composition comprising botulinum neurotoxin A2
|
|
WO2006013370A1
(en)
|
2004-08-04 |
2006-02-09 |
Ipsen Limited |
Pharmaceutical composition containing botulinum neurotoxin a2
|
|
US7429386B2
(en)
|
2004-09-03 |
2008-09-30 |
Allergan, Inc. |
Stretch mark treatment
|
|
US7179474B2
(en)
*
|
2004-09-03 |
2007-02-20 |
Allergan, Inc. |
Methods for treating a buttock deformity
|
|
US7727537B2
(en)
|
2005-02-14 |
2010-06-01 |
Dpm Therapeutics Corp. |
Stabilized compositions for topical administration and methods of making same
|
|
DK1853623T3
(da)
|
2005-03-03 |
2013-07-15 |
Allergan Inc |
Dyreprodukt-frit system og fremgangsmåde til oprensning af et botulinumtoksin
|
|
US7419675B2
(en)
*
|
2005-05-26 |
2008-09-02 |
Allergan, Inc. |
Method for treating peritoneal adhesions
|
|
WO2006133193A1
(en)
*
|
2005-06-07 |
2006-12-14 |
American Medical Systems Research Corporation |
Injection guidance system and method
|
|
US20070038089A1
(en)
*
|
2005-06-29 |
2007-02-15 |
Olympus Medical Systems Corp. |
Transurethral diagnostic method and treatment method using ultrasonic endoscope
|
|
WO2008010788A2
(en)
*
|
2005-07-18 |
2008-01-24 |
University Of Massachusetts Lowell |
Compositions and methods for making and using nanoemulsions
|
|
US7910116B2
(en)
*
|
2005-08-24 |
2011-03-22 |
Allergan, Inc. |
Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
|
|
WO2007044748A2
(en)
*
|
2005-10-11 |
2007-04-19 |
University Of Pittsburgh |
Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
KR20080071615A
(ko)
|
2005-12-01 |
2008-08-04 |
유니버시티 오브 메사츄세츠 로웰 |
보툴리눔 나노에멀젼
|
|
US20090312696A1
(en)
*
|
2005-12-28 |
2009-12-17 |
Copa Vincent G |
Devices, Systems, and Related Methods for Delivery of Fluid to Tissue
|
|
WO2007106874A2
(en)
*
|
2006-03-14 |
2007-09-20 |
Autocraft Industries, Inc. |
Improved wheelchair
|
|
US7794386B2
(en)
|
2006-03-15 |
2010-09-14 |
Allergan, Inc. |
Methods for facilitating weight loss
|
|
US7811586B2
(en)
*
|
2006-05-02 |
2010-10-12 |
Allergan, Inc. |
Methods for alleviating testicular pain
|
|
US20090304747A1
(en)
*
|
2006-05-16 |
2009-12-10 |
Mayo Foundation For Medical Education And Research |
Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders
|
|
AR061669A1
(es)
|
2006-06-29 |
2008-09-10 |
Merz Pharma Gmbh & Co Kgaa |
Aplicacion de alta frecuencia de terapia con toxina botulinica
|
|
US10792344B2
(en)
|
2006-06-29 |
2020-10-06 |
Merz Pharma Gmbh & Co. Kgaa |
High frequency application of botulinum toxin therapy
|
|
US20080092910A1
(en)
*
|
2006-10-18 |
2008-04-24 |
Allergan, Inc. |
Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures
|
|
US20080113051A1
(en)
*
|
2006-11-13 |
2008-05-15 |
Allergan, Inc. |
Methods for alleviating tattoo pain
|
|
JP2010528981A
(ja)
*
|
2006-12-01 |
2010-08-26 |
アンテリオス， インコーポレイテッド |
両親媒性実体ナノ粒子
|
|
SG179457A1
(en)
|
2006-12-01 |
2012-04-27 |
Anterios Inc |
Peptide nanoparticles and uses therefor
|
|
JP2010519211A
(ja)
*
|
2007-02-15 |
2010-06-03 |
アラーガン、インコーポレイテッド |
膀胱もしくは前立腺障害または多汗症を処置するためのボツリヌス毒素および酵素の使用
|
|
KR20100050443A
(ko)
|
2007-05-31 |
2010-05-13 |
안테리오스, 인코퍼레이티드 |
핵산 나노입자 및 이의 용도
|
|
RU2010120016A
(ru)
*
|
2007-10-23 |
2011-11-27 |
Аллерган, Инк. (Us) |
Способы лечения хронического нейрогенного воспаления с применением модифицированных клостридиальных токсинов
|
|
US8470337B2
(en)
*
|
2008-03-13 |
2013-06-25 |
Allergan, Inc. |
Therapeutic treatments using botulinum neurotoxin
|
|
EP3650017A1
(en)
*
|
2008-06-26 |
2020-05-13 |
Anterios, Inc. |
Dermal delivery
|
|
WO2010096134A1
(en)
|
2008-12-04 |
2010-08-26 |
Botulinum Toxin Research Associates, Inc. |
Extended length botulinum toxin formulation for human or mammalian use
|
|
EP2376104A4
(en)
*
|
2008-12-15 |
2014-09-10 |
Protox Therapeutics Inc |
Method of treating prostatitis with proaeryslyin, modified pore-forming protein
|
|
US20100166739A1
(en)
*
|
2008-12-30 |
2010-07-01 |
Lipella Paharmaceuticals Inc. |
Methods and Compositions for Diagnosing Urological Disorders
|
|
US8133491B1
(en)
|
2009-01-30 |
2012-03-13 |
The University Of Toledo |
Compositions and methods for treatment of hyperplastic disorders
|
|
AU2010221435B2
(en)
|
2009-03-06 |
2014-06-19 |
Allergan, Inc. |
Clostridial toxin to improve ejaculate
|
|
US20100303756A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Urogenital-Neurological Disorders Using Interleukin Retargeted Endopepidases
|
|
US20100303788A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases
|
|
US20100303791A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Chronic Neurogenic Inflammation Using Glucagon Like Hormone Retargeted Endopepidases
|
|
US20100303794A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases
|
|
US8198229B2
(en)
|
2009-05-29 |
2012-06-12 |
Allergan, Inc. |
Methods of treating urogenital-neurological disorders using galanin retargeted endopepidases
|
|
US20100303798A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Urogenital-Neurological Disorders Using Neurotrophin Retargeted Endopepidases
|
|
US20100303789A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Chronic Neurogenic Inflammation Using Neurotrophin Retargeted Endopepidases
|
|
US20100303783A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases
|
|
US8147848B2
(en)
|
2009-08-26 |
2012-04-03 |
Allergan, Inc. |
Method for treating premature ejaculation with a botulinum neurotoxin
|
|
US9125907B2
(en)
|
2009-09-30 |
2015-09-08 |
Christopher Shaari |
Use of botulinum neurotoxin to treat substance addictions
|
|
WO2012024286A2
(en)
|
2010-08-18 |
2012-02-23 |
Medtronic, Inc. |
Urgency therapy with neuromodulation and c-afferent nerve desensitization
|
|
WO2012109387A1
(en)
|
2011-02-08 |
2012-08-16 |
Halozyme, Inc. |
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
|
|
US20120207733A1
(en)
*
|
2011-02-14 |
2012-08-16 |
Allergan, Inc. |
Treating a Disease of Hyperproliferation Using Retargeted Endopeptidases
|
|
US20140140983A1
(en)
|
2011-07-08 |
2014-05-22 |
Allergan, Inc. |
Method for treatment of autonomic nervous system disorders
|
|
US8992941B2
(en)
|
2011-07-08 |
2015-03-31 |
Allergan, Inc. |
Method for treatment of esophageal spasm
|
|
EP2731620A1
(en)
*
|
2011-07-14 |
2014-05-21 |
Allergan, Inc. |
Methods for treatment of incontinence associated with sexual activity
|
|
US20140127188A1
(en)
|
2011-07-20 |
2014-05-08 |
Katherine Cernok |
Method for treatment of adipose deposits
|
|
US20130171122A1
(en)
*
|
2011-12-29 |
2013-07-04 |
Allergan, Inc. |
Endopeptidase and neurotoxin combination treatment of bladder disorders
|
|
RU2635466C2
(ru)
*
|
2012-04-08 |
2017-11-13 |
Теракоат Лтд |
Препараты термообратимого гидрогеля для применения при лечении нарушений уротелия
|
|
US9393291B2
(en)
|
2012-04-12 |
2016-07-19 |
Botulinum Toxin Research Associates, Inc. |
Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds
|
|
US10149893B2
(en)
|
2013-09-24 |
2018-12-11 |
Allergan, Inc. |
Methods for modifying progression of osteoarthritis
|
|
US9901627B2
(en)
|
2014-07-18 |
2018-02-27 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
MX2017009985A
(es)
*
|
2015-02-03 |
2017-10-19 |
Höganäs Ab (Publ) |
Composicion metalica en polvo para facilitar el maquinado.
|
|
MA45492A
(fr)
|
2016-06-23 |
2019-05-01 |
Hopitaux Paris Assist Publique |
Vecteurs viraux pour le traitement de l'hyperactivité vésicale neurogène
|
|
WO2018038301A1
(en)
|
2016-08-26 |
2018-03-01 |
Hugel Inc. |
Stabilized liquid formulation of botulinum toxin and preparation method thereof
|
|
JP2019526611A
(ja)
|
2016-09-13 |
2019-09-19 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
非タンパク質クロストリジウム毒素組成物
|
|
BR112019010131A2
(pt)
|
2016-11-21 |
2019-10-08 |
Eirion Therapeutics, Inc. |
entrega transdérmica de agentes grandes
|
|
EP3470054B1
(en)
|
2017-10-11 |
2023-09-20 |
Hugel Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
US10792400B2
(en)
|
2017-10-12 |
2020-10-06 |
Hugel Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
US10525111B2
(en)
|
2017-10-12 |
2020-01-07 |
Hugel, Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
RU2687106C1
(ru)
*
|
2017-12-19 |
2019-05-07 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ |
Способ лечения синдрома гиперактивного мочевого пузыря
|
|
EP3825689A3
(en)
|
2018-11-29 |
2021-09-15 |
Hugel Inc. |
A cell-based method for determining an activity of botulinum toxin
|
|
CN110935009B
(zh)
*
|
2019-12-24 |
2023-07-11 |
云南南诏药业有限公司 |
科博肽制剂在制备治疗痔疮药物中的应用
|
|
RU2768606C1
(ru)
*
|
2021-04-16 |
2022-03-24 |
Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр колопроктологии имени А.Н. Рыжих" Министерства здравоохранения Российской Федерации |
Способ комбинированного хирургического лечения хронической анальной трещины со спазмом сфинктера методом иссечения трещины в сочетании с инъекцией ботулинического токсина типа А в дозировке 40 ЕД во внутренний анальный сфинктер под ультразвуковой навигацией
|